English
简体中文
Total: £ 56.28
Published Date: 2025-11-06 | Pages: 122 | Tables: 127 | Medical Care
The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) was estimated to be worth US$ 7109 million in 2024 and is forecast to a readjusted size of US$ 12650 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
Market Driver:
The Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by the growing demand for rapid and accurate diagnostic tools for infectious diseases, genetic disorders, and cancer. INAAT's ability to deliver high sensitivity and specificity without the need for complex thermal cycling equipment makes it ideal for point-of-care testing and use in resource-limited settings. Additionally, the rise in global health concerns, such as pandemics, has increased the adoption of INAAT for quick and reliable pathogen detection.
Market Challenge:
A significant challenge in the INAAT market is the high cost of specialized reagents and kits, which can limit accessibility in developing regions. The technology's complexity and the need for skilled personnel to interpret results may hinder widespread adoption in low-resource settings. Moreover, competition from established technologies like PCR and emerging alternatives creates pressure for differentiation and cost-effectiveness.
Industry Trends:
The INAAT industry is witnessing advancements in portable and user-friendly diagnostic devices, enabling real-time testing in non-laboratory environments. Integration with microfluidics and smartphone-based detection systems is enhancing accessibility and convenience. There is also a growing focus on multiplex INAAT assays capable of detecting multiple targets simultaneously, increasing diagnostic efficiency. Collaborations between biotech firms and healthcare organizations are fostering innovation and expanding the application of INAAT in personalized medicine and global health initiatives.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Isothermal Nucleic Acid Amplification Technology (INAAT), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) by region & country, by Type, and by Application.
The Isothermal Nucleic Acid Amplification Technology (INAAT) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology (INAAT).
Market Segmentation
By Company
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Thermo Fisher Scientific
MeG Biotech
BioLabs
Mast Group
Segment by Type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segment by Application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Isothermal Nucleic Acid Amplification Technology (INAAT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Isothermal Nucleic Acid Amplification Technology (INAAT) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Product Introduction
1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Forecast (2020-2031)
1.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends & Drivers
1.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Trends
1.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers & Opportunity
1.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
1.3.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Players Revenue Ranking (2024)
2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Company (2020-2025)
2.3 Key Companies Isothermal Nucleic Acid Amplification Technology (INAAT) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
2.5 Key Companies Time to Begin Mass Production of Isothermal Nucleic Acid Amplification Technology (INAAT)
2.6 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Analysis
2.6.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 LAMP
3.1.2 TMA
3.1.3 NEAR
3.1.4 NASBA
3.1.5 HDA
3.1.6 SPIA
3.1.7 Other
3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type
3.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, by Type (2020-2031)
3.2.3 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Diagnostic
4.1.2 Scientific Research
4.1.3 Food Testing
4.1.4 Environmental Hygiene
4.1.5 Other
4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application
4.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, by Application (2020-2031)
4.2.3 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region
5.1.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (2020-2025)
5.1.3 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (2026-2031)
5.1.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
5.2.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
5.3.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
5.4.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
5.5.2 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
5.6.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.3 United States
6.3.1 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.3.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.4.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.5.2 China Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.6.2 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.7.2 South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.8.2 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020-2031
6.9.2 India Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.1.4 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.1.5 Abbott Recent Developments
7.2 BioMerieux
7.2.1 BioMerieux Profile
7.2.2 BioMerieux Main Business
7.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.2.4 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.2.5 BioMerieux Recent Developments
7.3 Hologic
7.3.1 Hologic Profile
7.3.2 Hologic Main Business
7.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.3.4 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.3.5 Hologic Recent Developments
7.4 BD
7.4.1 BD Profile
7.4.2 BD Main Business
7.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.4.4 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.4.5 BD Recent Developments
7.5 Grifols
7.5.1 Grifols Profile
7.5.2 Grifols Main Business
7.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.5.4 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.5.5 Grifols Recent Developments
7.6 Quidel
7.6.1 Quidel Profile
7.6.2 Quidel Main Business
7.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.6.4 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.6.5 Quidel Recent Developments
7.7 Meridian Bioscience
7.7.1 Meridian Bioscience Profile
7.7.2 Meridian Bioscience Main Business
7.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.7.4 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.7.5 Meridian Bioscience Recent Developments
7.8 Qiagen
7.8.1 Qiagen Profile
7.8.2 Qiagen Main Business
7.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.8.4 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.8.5 Qiagen Recent Developments
7.9 Eiken Chemical
7.9.1 Eiken Chemical Profile
7.9.2 Eiken Chemical Main Business
7.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.9.4 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.9.5 Eiken Chemical Recent Developments
7.10 OptiGene
7.10.1 OptiGene Profile
7.10.2 OptiGene Main Business
7.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.10.4 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.10.5 OptiGene Recent Developments
7.11 HiberGene Diagnostic
7.11.1 HiberGene Diagnostic Profile
7.11.2 HiberGene Diagnostic Main Business
7.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.11.4 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.11.5 HiberGene Diagnostic Recent Developments
7.12 Lucigen
7.12.1 Lucigen Profile
7.12.2 Lucigen Main Business
7.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.12.4 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.12.5 Lucigen Recent Developments
7.13 Nippon Gene
7.13.1 Nippon Gene Profile
7.13.2 Nippon Gene Main Business
7.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.13.4 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.13.5 Nippon Gene Recent Developments
7.14 Mast Group
7.14.1 Mast Group Profile
7.14.2 Mast Group Main Business
7.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.14.4 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.14.5 Mast Group Recent Developments
7.15 New England Biolabs
7.15.1 New England Biolabs Profile
7.15.2 New England Biolabs Main Business
7.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.15.4 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.15.5 New England Biolabs Recent Developments
7.16 Ustar Biotechnologies
7.16.1 Ustar Biotechnologies Profile
7.16.2 Ustar Biotechnologies Main Business
7.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.16.4 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.16.5 Ustar Biotechnologies Recent Developments
7.17 Thermo Fisher Scientific
7.17.1 Thermo Fisher Scientific Profile
7.17.2 Thermo Fisher Scientific Main Business
7.17.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.17.4 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.17.5 Thermo Fisher Scientific Recent Developments
7.18 MeG Biotech
7.18.1 MeG Biotech Profile
7.18.2 MeG Biotech Main Business
7.18.3 MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.18.4 MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.18.5 MeG Biotech Recent Developments
7.19 BioLabs
7.19.1 BioLabs Profile
7.19.2 BioLabs Main Business
7.19.3 BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.19.4 BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.19.5 BioLabs Recent Developments
7.20 Mast Group
7.20.1 Mast Group Profile
7.20.2 Mast Group Main Business
7.20.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
7.20.4 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (US$ Million) & (2020-2025)
7.20.5 Mast Group Recent Developments
8 Industry Chain Analysis
8.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Industrial Chain
8.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Model
8.5.2 Sales Channel
8.5.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends
Table 2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers & Opportunity
Table 3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
Table 4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
Table 5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Isothermal Nucleic Acid Amplification Technology (INAAT) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Isothermal Nucleic Acid Amplification Technology (INAAT) Product Type
Table 9. Key Companies Time to Begin Mass Production of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 10. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Market Share in Value by Type (2020-2025)
Table 17. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Market Share in Value by Type (2026-2031)
Table 18. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Market Share in Value by Application (2020-2025)
Table 22. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Market Share in Value by Application (2026-2031)
Table 23. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (2020-2025) & (%)
Table 27. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2026-2031) & (US$ Million)
Table 31. Abbott Basic Information List
Table 32. Abbott Description and Business Overview
Table 33. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 34. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Abbott (2020-2025)
Table 35. Abbott Recent Developments
Table 36. BioMerieux Basic Information List
Table 37. BioMerieux Description and Business Overview
Table 38. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 39. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of BioMerieux (2020-2025)
Table 40. BioMerieux Recent Developments
Table 41. Hologic Basic Information List
Table 42. Hologic Description and Business Overview
Table 43. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 44. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Hologic (2020-2025)
Table 45. Hologic Recent Developments
Table 46. BD Basic Information List
Table 47. BD Description and Business Overview
Table 48. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 49. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of BD (2020-2025)
Table 50. BD Recent Developments
Table 51. Grifols Basic Information List
Table 52. Grifols Description and Business Overview
Table 53. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 54. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Grifols (2020-2025)
Table 55. Grifols Recent Developments
Table 56. Quidel Basic Information List
Table 57. Quidel Description and Business Overview
Table 58. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 59. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Quidel (2020-2025)
Table 60. Quidel Recent Developments
Table 61. Meridian Bioscience Basic Information List
Table 62. Meridian Bioscience Description and Business Overview
Table 63. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 64. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Meridian Bioscience (2020-2025)
Table 65. Meridian Bioscience Recent Developments
Table 66. Qiagen Basic Information List
Table 67. Qiagen Description and Business Overview
Table 68. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 69. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Qiagen (2020-2025)
Table 70. Qiagen Recent Developments
Table 71. Eiken Chemical Basic Information List
Table 72. Eiken Chemical Description and Business Overview
Table 73. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 74. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Eiken Chemical (2020-2025)
Table 75. Eiken Chemical Recent Developments
Table 76. OptiGene Basic Information List
Table 77. OptiGene Description and Business Overview
Table 78. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 79. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of OptiGene (2020-2025)
Table 80. OptiGene Recent Developments
Table 81. HiberGene Diagnostic Basic Information List
Table 82. HiberGene Diagnostic Description and Business Overview
Table 83. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 84. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of HiberGene Diagnostic (2020-2025)
Table 85. HiberGene Diagnostic Recent Developments
Table 86. Lucigen Basic Information List
Table 87. Lucigen Description and Business Overview
Table 88. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 89. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Lucigen (2020-2025)
Table 90. Lucigen Recent Developments
Table 91. Nippon Gene Basic Information List
Table 92. Nippon Gene Description and Business Overview
Table 93. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 94. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Nippon Gene (2020-2025)
Table 95. Nippon Gene Recent Developments
Table 96. Mast Group Basic Information List
Table 97. Mast Group Description and Business Overview
Table 98. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 99. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Mast Group (2020-2025)
Table 100. Mast Group Recent Developments
Table 101. New England Biolabs Basic Information List
Table 102. New England Biolabs Description and Business Overview
Table 103. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 104. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of New England Biolabs (2020-2025)
Table 105. New England Biolabs Recent Developments
Table 106. Ustar Biotechnologies Basic Information List
Table 107. Ustar Biotechnologies Description and Business Overview
Table 108. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 109. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Ustar Biotechnologies (2020-2025)
Table 110. Ustar Biotechnologies Recent Developments
Table 111. Thermo Fisher Scientific Basic Information List
Table 112. Thermo Fisher Scientific Description and Business Overview
Table 113. Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 114. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Thermo Fisher Scientific (2020-2025)
Table 115. Thermo Fisher Scientific Recent Developments
Table 116. MeG Biotech Basic Information List
Table 117. MeG Biotech Description and Business Overview
Table 118. MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 119. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of MeG Biotech (2020-2025)
Table 120. MeG Biotech Recent Developments
Table 121. BioLabs Basic Information List
Table 122. BioLabs Description and Business Overview
Table 123. BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 124. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of BioLabs (2020-2025)
Table 125. BioLabs Recent Developments
Table 126. Mast Group Basic Information List
Table 127. Mast Group Description and Business Overview
Table 128. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Products, Services and Solutions
Table 129. Revenue (US$ Million) in Isothermal Nucleic Acid Amplification Technology (INAAT) Business of Mast Group (2020-2025)
Table 130. Mast Group Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Isothermal Nucleic Acid Amplification Technology (INAAT) Downstream Customers
Table 134. Isothermal Nucleic Acid Amplification Technology (INAAT) Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Isothermal Nucleic Acid Amplification Technology (INAAT) Product Picture
Figure 2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value (2020-2031) & (US$ Million)
Figure 4. Isothermal Nucleic Acid Amplification Technology (INAAT) Report Years Considered
Figure 5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2024
Figure 7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. LAMP Picture
Figure 9. TMA Picture
Figure 10. NEAR Picture
Figure 11. NASBA Picture
Figure 12. HDA Picture
Figure 13. SPIA Picture
Figure 14. Other Picture
Figure 15. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value Market Share by Type, 2024 & 2031
Figure 17. Product Picture of Medical Diagnostic
Figure 18. Product Picture of Scientific Research
Figure 19. Product Picture of Food Testing
Figure 20. Product Picture of Environmental Hygiene
Figure 21. Product Picture of Other
Figure 22. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value Market Share by Application, 2024 & 2031
Figure 24. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value (2020-2031) & (US$ Million)
Figure 25. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
Figure 26. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 27. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
Figure 28. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 29. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Region (%), 2024 VS 2031
Figure 30. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 31. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
Figure 32. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 33. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Country (%), 2024 VS 2031
Figure 34. Key Countries/Regions Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value (%), (2020-2031)
Figure 35. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 36. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 37. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 38. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 39. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 40. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 41. China Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 42. China Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 43. China Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 44. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 45. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 46. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 47. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 48. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 49. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 50. Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 51. Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 52. Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 53. India Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value, (2020-2031) & (US$ Million)
Figure 54. India Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Type (%), 2024 VS 2031
Figure 55. India Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Value by Application (%), 2024 VS 2031
Figure 56. Isothermal Nucleic Acid Amplification Technology (INAAT) Industrial Chain
Figure 57. Isothermal Nucleic Acid Amplification Technology (INAAT) Manufacturing Cost Structure
Figure 58. Channels of Distribution (Direct Sales, and Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
